Amgen (NQ: AMGN )
255.71 USD +0.58 (+0.23%) Official Closing Price Updated: 7:45 PM EDT, Apr 16, 2021 Add to My Watchlist
Press releases about Amgen
Ligand Announces Amgen’s KYPROLIS® Approved by FDA as Combination Regimen with DARZALEX® and Dexamethasone in Once- and Twice-Weekly Dosing Regimens for Patients with Relapsed/Refractory Multiple Myel
August 24, 2020
Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) announces that a major Captisol customer Amgen (NASDAQ: AMGN) has received U.S. Food and Drug Administration (FDA) approval for the expansion of the...
FDA Approves New KYPROLIS® (carfilzomib) Combination Regimen With DARZALEX® (daratumumab) And Dexamethasone In Both Once- And Twice-Weekly Dosing Regimens
August 20, 2020
Approval Based on the CANDOR and EQUULEUS Studies in Patients With Relapsed/Refractory Multiple Myeloma
Amgen Announces Pricing Terms For Senior Notes Exchange Offers, Increases The Maximum Notes Exchange Cap And Accepts Tendered Notes
August 13, 2020
Amgen Inc. (NASDAQ:AMGN) announced today the pricing terms of its previously announced nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers")...
Amgen Inc. (NASDAQ:AMGN) announced today the early tender results of its previously announced nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange...
Members Of The COVID R&D Alliance And Quantum Leap Healthcare Collaborative Enroll First Patients In I-SPY COVID Trial
August 03, 2020
- I-SPY COVID will evaluate the impact of cenicriviroc, Otezla®, and Firazyr® on inflammatory response in COVID-19 patients
Amgen Commences Exchange Offers For Certain Series Of Outstanding Senior Notes From Exchange Eligible Holders
July 30, 2020
Amgen Inc. (NASDAQ: AMGN) announced today the commencement of nine separate private offers to exchange (each, an "Exchange Offer" and, collectively, the "Exchange Offers") certain specified series of...
Amgen Reports Second Quarter 2020 Financial Results
July 28, 2020
Amgen (NASDAQ:AMGN) today announced that it will report its second quarter financial results on Tuesday, July 28, 2020, after the close of the U.S. financial markets. The announcement will be followed...
Amgen Announces 2020 Third Quarter Dividend
July 23, 2020
Amgen (NASDAQ:AMGN) today announced that its Board of Directors declared a $1.60 per share dividend for the third quarter of 2020. The dividend will be paid on September 8, 2020, to all stockholders of...
Amgen Appoints Amy E. Miles To Board Of Directors
July 23, 2020
Amgen today announced the appointment of Amy E. Miles to its Board of Directors, effective July 23, 2020. Ms. Miles will serve as a member of the Board's Audit Committee and Governance and Nominating...
Amgen Foundation Awards Khan Academy An Additional $3 Million To Support Science Learning And Educational Equity Amid COVID-19
July 21, 2020
Foundation Expands Five-Year Relationship to Include Support for School Districts Facing Deep Budget Cuts
Amgen Announces Additional Investment In BeiGene
July 12, 2020
Amgen (NASDAQ:AMGN) today announced an additional investment of approximately $421 million in BeiGene's registered direct offering of ordinary shares, which maintains Amgen's current pro rata ownership...
Appeals Court Affirms Validity Of Enbrel® (etanercept) Patents Injunction Against Sandoz's Infringement Stands
July 01, 2020
Amgen today announced that the United States Court of Appeals for the Federal Circuit has held in Amgen's favor on the validity of two patents that describe and claim Enbrel® (etanercept) and methods...
deCODE Genetics: Loss of Function Variant in FLT3 Strongly Increases the Risk of Autoimmune Thyroid Disease and Other Autoimmune Diseases
June 24, 2020
The combination of genomics, transcriptomics and proteomics sheds light on autoimmune thyroid disease, other autoimmune diseases and AML
Launch of EIU report showing lack of integrated follow up care can increase risk of subsequent heart attack or stroke in APAC economies
June 23, 2020
From ACN Newswire
Amgen Is Supporting Advancement Of AMG 634 For Global Health Diseases In Developing Countries
June 22, 2020
Amgen (NASDAQ: AMGN) today announced it is supporting the further study of AMG 634, a phosphodiesterase type 4 (PDE4) inhibitor, for the treatment of tuberculosis (TB) and erythema nodosum leprosum...
Amgen To Present At The BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference
June 18, 2020
Amgen (NASDAQ: AMGN) will present at the BMO Capital Markets 2020 Prescriptions for Success Healthcare Conference at 4:00 p.m. ET on Tuesday, June 23, 2020. Elliott Levy, senior vice president of R&D...
Amgen (NASDAQ:AMGN) will present at the Goldman Sachs 41st Annual Virtual Global Healthcare Conference on Wednesday, June 10, 2020 at 1:20 p.m. ET. Peter H. Griffith, executive vice president and chief...
David Meline Joins Moderna as Chief Financial Officer
June 04, 2020
Amgen Presents New AMG 510 Clinical Data Across Multiple Solid Tumors During ASCO20 Virtual Scientific Program
May 29, 2020
Amgen (NASDAQ: AMGN) will present at the Jefferies 2020 Virtual Healthcare Conference at 4:00 p.m. ET on Tuesday, June 2, 2020. David M. Reese, M.D., executive vice president of Research and...
Amgen To Webcast Investor Meeting At 56th Annual Meeting Of The American Society Of Clinical Oncology (ASCO)
May 26, 2020
Amgen (NASDAQ: AMGN) will host a webcast call for the investment community in conjunction with the ASCO20 Virtual Scientific Program on Friday, May 29, at 1:00 p.m. PT. David M. Reese, M.D., executive...
Amgen (NASDAQ:AMGN) today announced voting results from the Company's Annual Meeting of Stockholders on May 20, 2020, held virtually this year due to the COVID-19 pandemic. More than 88 percent of...
Amgen Showcases Oncology Pipeline At ASCO 2020
May 13, 2020
Updated Data Evaluating Sotorasib (AMG 510), a First-in-Class Investigational KRASG12C Inhibitor, in Colorectal Cancer and Other Solid Tumors
Amgen To Present At The Bank Of America Merrill Lynch Virtual Global Healthcare Conference
May 12, 2020
Amgen (NASDAQ:AMGN) will present at the Bank of America Merrill Lynch Virtual Global Healthcare Conference at 1:40 p.m. ET on Thursday, May 14. Peter H. Griffith, executive vice president and chief...